by Melbourne HealthCredit: CC0 Public DomainA new study—the largest of its kind globally—has found children with multiple sclerosis (MS) have better outcomes if treated early and with the same high-ef
by Melbourne HealthCredit: CC0 Public DomainA new study—the largest of its kind globally—has found children with multiple sclerosis (MS) have better outcomes if treated early and with the same high-ef
by Karolinska InstitutetIn a new study, an international research team shows that a medical nutrition-drink, consisting of, among other things, essential fatty acids and vitamins, may have an imp
by Karolinska InstitutetIn a new study, an international research team shows that a medical nutrition-drink, consisting of, among other things, essential fatty acids and vitamins, may have an imp
byUniversity of MinnesotaIntroduction and overview of Cap-QuIC method. Credit:npj Biosensing(2024). DOI: 10.1038/s44328-024-00003-0Researchers at the University of Minnesota have dev
byUniversity of MinnesotaIntroduction and overview of Cap-QuIC method. Credit:npj Biosensing(2024). DOI: 10.1038/s44328-024-00003-0Researchers at the University of Minnesota have dev
byVIB (the Flanders Institute for Biotechnology)Mouse cortex (in blue) transplanted with human neurons (in green). Credit: VIBThe mechanisms underlying intellectual disabilities or autism remain
byVIB (the Flanders Institute for Biotechnology)Mouse cortex (in blue) transplanted with human neurons (in green). Credit: VIBThe mechanisms underlying intellectual disabilities or autism remain
by University of OxfordCredit: AI-generated imageRoutine brain scanning in people experiencing psychosis could help to identify underlying physical conditions that are causing their symptoms, acc
by University of OxfordCredit: AI-generated imageRoutine brain scanning in people experiencing psychosis could help to identify underlying physical conditions that are causing their symptoms, acc
by Karolinska InstitutetCredit: Karolinska InstitutetResearchers at Karolinska Institutet have imaged tau protein in the brains of living patients with Alzheimer's disease. The amount and spr
by Karolinska InstitutetCredit: Karolinska InstitutetResearchers at Karolinska Institutet have imaged tau protein in the brains of living patients with Alzheimer's disease. The amount and spr
by Lisa Marshall,University of Colorado at BoulderGraphical abstract. Credit:Neuron(2021). DOI: 10.1016/j.neuron.2021.03.026Look deep inside the brain of someone with Alzheimer's
by Lisa Marshall,University of Colorado at BoulderGraphical abstract. Credit:Neuron(2021). DOI: 10.1016/j.neuron.2021.03.026Look deep inside the brain of someone with Alzheimer's
by American College of CardiologyCredit: CC0 Public DomainPeople with a higher risk of developing cardiovascular disease have increased cognitive decline, including an increase in typical markers
by American College of CardiologyCredit: CC0 Public DomainPeople with a higher risk of developing cardiovascular disease have increased cognitive decline, including an increase in typical markers
by Enrique Rivero,University of California, Los AngelesDr. David Reuben, Archstone Professor of Medicine and chief of the Division of Geriatrics in the David Geffen School of Medicine at UCLA. C
by Enrique Rivero,University of California, Los AngelesDr. David Reuben, Archstone Professor of Medicine and chief of the Division of Geriatrics in the David Geffen School of Medicine at UCLA. C
MARCH 1, 2024by Elana GotkineSchizophrenia is associated with an increased risk of subsequent cardiovascular disease (CVD) events, with the association stronger in women, according to a study publishe
MARCH 1, 2024by Elana GotkineSchizophrenia is associated with an increased risk of subsequent cardiovascular disease (CVD) events, with the association stronger in women, according to a study publishe
by Paul Mayne,University of Western OntarioRobarts Research Institute scientists Vania and Marco Prado have found a gene, TRPM2, that could be a therapeutic target to assist in decreasing cognit
by Paul Mayne,University of Western OntarioRobarts Research Institute scientists Vania and Marco Prado have found a gene, TRPM2, that could be a therapeutic target to assist in decreasing cognit